Literature DB >> 1651829

Mechanism of action of arginine vasopressin on acute ischemic brain edema.

X F Liu1, Y M Shi, B C Lin.   

Abstract

The purpose of this experiment is to study the role of arginine vasopressin (AVP) in acute cerebral ischemic edema in Mongolian gerbils. The results show that intracerebroventricular injection (ICV) of AVP exacerbates acute ischemic brain edema, while ICV of AVP antiserum significantly decreases the ischemic brain edema. Nimodipine (calcium antagonist) cannot block this role of AVP in brain edema. In addition, the cortical Na(+)-K+ ATPase activity is significantly decreased, while the cAMP content of ischemic cortex and hypothalamus and the cGMP content of the hypothalamus are markedly increased after AVP ICV. These suggest that AVP may play an important role in the pathophysiologic process of ischemic brain edema by inhibiting the Na(+)-K+ ATPase activity of the cerebral cell membrane and the AVP receptors mediated by cAMP and cGMP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651829

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.

Authors:  Sandro M Krieg; Sebastian Sonanini; Nikolaus Plesnila; Raimund Trabold
Journal:  J Neurotrauma       Date:  2014-12-16       Impact factor: 5.269

2.  Evaluating the involvement of cerebral microvascular endothelial Na+/K+-ATPase and Na+-K+-2Cl- co-transporter in electrolyte fluxes in an in vitro blood-brain barrier model of dehydration.

Authors:  Kasper Lykke; Mette Assentoft; Sofie Hørlyck; Hans Cc Helms; Anca Stoica; Trine L Toft-Bertelsen; Katerina Tritsaris; Frederik Vilhardt; Birger Brodin; Nanna MacAulay
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-10       Impact factor: 6.200

3.  Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.

Authors:  Xiaoqin Liu; Shin Nakayama; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

4.  Antagonists of the Vasopressin V1 Receptor and of the β(1)-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes - but the Mechanisms Differ.

Authors:  Leif Hertz; Junnan Xu; Ye Chen; Marie E Gibbs; Ting Du; Leif Hertz; Junnan Xu; Ye Chen; Marie E Gibbs; Ting Du
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.